EUVIMEDEUVIMED entdecken
Open Access

Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway

Xueqin Chen, Juan Shen, Zhifei Xu, Bo Xu, Jie Huang, Jingjing Jiang, Yidan Chen, Xin Li, Shaoyu Yang, Kan Wu, Jiaoli Wang, Peihua Luo und 4 weitere

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.129604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Xueqin Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang 310006, PR …. Hauptthemen laut MEDLINE: Quinolines, Indoles, Lung Neoplasms, Docetaxel. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesIndolesLung NeoplasmsDocetaxelDiscoidin Domain Receptor 1Carcinoma, Non-Small-Cell LungHumansGlycolysisAnimalsCell Line, TumorMicePhosphorylationAntineoplastic AgentsMice, NudeCell Proliferation

Stichwörter der Autor:innen

DDR1anlotinibdocetaxelglycolysissensitivity

Substanzen

anlotinibQuinolinesIndolesDocetaxelDiscoidin Domain Receptor 1DDR1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Thoracic Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang 310006, PR China.
  • Department of Thoracic Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, PR China.
  • Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, PR China.
  • Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, PR China.
  • Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang 310018, PR China.
  • School of Medicine, Hangzhou City University, Hangzhou, Zhejiang 310015, PR China.

Zitieren

APA

Chen, X., Shen, J., Xu, Z., Xu, B., Huang, J., Jiang, J., Chen, Y., Li, X., Yang, S., Wu, K., Wang, J., Luo, P., He, Q., Ma, S., Xia, B., & Yang, B. (2026). Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.129604

Vancouver

Chen X, Shen J, Xu Z, Xu B, Huang J, Jiang J, et al. Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.129604

BibTeX
@article{Chen2026,
  author = {Chen, Xueqin and Shen, Juan and Xu, Zhifei and Xu, Bo and Huang, Jie and Jiang, Jingjing and Chen, Yidan and Li, Xin and Yang, Shaoyu and Wu, Kan and Wang, Jiaoli and Luo, Peihua and He, Qiaojun and Ma, Shenglin and Xia, Bing and Yang, Bo},
  title = {Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.129604}
}
Kostenlos starten →